Global Molecular Diagnostics Market Research and Forecast, 2018-2023
|発行||Orion Market Research Pvt Ltd||商品コード||785704|
|分子診断の世界市場の分析と予測 Global Molecular Diagnostics Market Research and Forecast, 2018-2023|
|出版日: 2019年01月21日||ページ情報: 英文||
当レポートでは、世界の分子診断市場の現状と見通しについて分析し、診断技術・関連疾患の概要や、市場の基本構造、外部からのマクロ的・ミクロ的影響、主な促進・抑制要因、世界全体および地域別の市場動向の見通し (今後6年間分)、セグメント別 (技術、製品、用途、エンドユーザーなど)の詳細動向、最新の市場競争状況、主要企業のプロファイルなどを調査しております。
Molecular diagnostics involves the application of a large array of techniques right from molecular biology to conducting a various test for analyzing biological markers in the genome and proteomes. The molecular diagnostic is used to keep close track of infectious disease, it's monitoring, risks involved and for various other purposes. The applicability of such diagnostic practice is highly in demand owing to the rising trend of personalized treatment and personalized medication. The major factor fueling the growth of the market is a rise in the prevalence of infectious diseases and also increasing cases of cancer across the globe. The demand for a cost-effective and accurate diagnostic solution is another factor propelling the growth of the market. On the contrary, the stringent laws and regulations related is the major factor restraining the growth of the market. The lack of adequate infrastructure in developing countries is one of the major hindrances in the growth of the market in emerging regions. The extended support of the government in terms of funding and technological advancement for the development of more precise and cost-effective diagnostic device will propel the market in future.
Based on the geography, the market is divided into North America, Europe, Asia-Pacific and Rest of the World. The emerging countries such as India and China in the Asia-Pacific region is expected to grow significantly during the forecast attributed to the rapid development of the healthcare industry in such regions. North America holds the major share in the molecular diagnostics market owing to the presence of a large number of companies both in development and research of molecular diagnostic fields, the region also has the highest statistics related with cancer incidence. The European region follows North America in market share owing to the availability of well-established healthcare facility and increasing demand for personalized treatment.
The companies engaged in molecular diagnostics provides reagent kits and testing equipment for molecular diagnostic test. The market players also provide molecular diagnostic services for treatment and diagnosis of infectious diseases and cancer. The key players in the molecular diagnostics market are Becton Dickinson and Co., Abbott Laboratories, Inc., bioMerieux S.A., Bio-Rad Laboratories, Inc., Danaher Corporation, Nanopore Technologies, QIAGEN N.V. and so on. The organizations such as Bio-Rad Laboratories, Inc. and Danaher Corporation, holds the major share of the molecular diagnostic market. The presence of a large number of companies makes the entire market highly competitive. An array of the organization is engaged in a clinical trial for applications of molecular diagnosis in personalized medicine development. Additionally, the organization such as Nanopore technologies has developed a point of care device which provides cost-effective sequencers.
The market study of the global molecular diagnostics market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
The report is intended for researchers in the healthcare segment, emerging companies and researchers in the market, investing companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.
Global molecular diagnostics market is segmented on the basis of various regions and below mentioned segments: